Mass Spectrometry–Based Proteomic Analysis of Urine in Acute Kidney Injury Following Cardiopulmonary Bypass: A Nested Case-Control Study
Received 5 June 2008; accepted 7 October 2008. published online 15 December 2008.
Refers to article:
Ironing Out the Pathogenesis of Acute Kidney Injury
Sangeeta Hingorani, Bruce A. Molitoris, Jonathan Himmelfarb
American Journal of Kidney Diseases
April 2009 (Vol. 53, Issue 4, Pages 569-571) Full Text |
Full-Text PDF (144 KB)
Background
The early evolution of acute kidney injury (AKI) in humans is difficult to study noninvasively. We hypothesized that urine proteomics could provide insight into the early pathophysiology of human AKI.
Study Design
A prospective nested case-control study (n = 250) compared serial urinary proteomes of 22 patients with AKI and 22 patients without AKI before, during, and after cardiopulmonary bypass surgery.
Outcomes
AKI was defined as a greater than 50% increase in serum creatinine level, and non-AKI, as less than 10% increase from baseline.
Measurements
Serum creatinine, urine protein-creatinine ratio, neutrophil gelatinase-associated lipocalin (NGAL), α1-microglobulin, interferon-inducible protein-10 (IP-10), monokine induced by interferon gamma (Mig), interferon-inducible T cell alpha chemoatractant (I-TAC), interleukin 6 (IL-6), IL-1β, and IL-10. Urine protein profiling by means of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
Results
SELDI-TOF-MS showed intraoperative tubular stress in both groups on arrival to the intensive care unit, evidenced by β2-microglobulinuria. Non-AKI proteomes returned toward baseline postoperatively. In contrast, AKI proteomes showed a second phase of tubular injury/stress with the reappearance of β2-microglobulin and multiple unidentified peaks (3 to 5 and 6 to 8 kDa) and the appearance of established tubular injury markers: urinary protein, α1-microglobulin, and NGAL. Furthermore, 2 novel peaks (2.43 and 2.78 kDa) were found to be dominant in postoperative non-AKI urine samples. The 2.78-kDa protein was identified as the active 25–amino acid form of hepcidin (hepcidin-25), a key regulator of iron homeostasis. Finally, an inflammatory component of reperfusion injury was evaluated by means of enzyme-linked immunosorbent assay analysis of candidate chemokines (IP-10, I-TAC, and Mig) and cytokines (IL-6, IL-1β, and IL-10). Of these, IP-10 was upregulated in patients with versus without AKI postoperatively.
Limitations
This is an observational study. SELDI-TOF-MS is a semiquantitative technique.
Conclusions
Evaluation of human AKI revealed early intraoperative tubular stress in all patients. A second phase of injury observed in patients with AKI may involve IP-10 recruitment of inflammatory cells. The enhancement of hepcidin-25 in patients without AKI may suggest a novel role for iron sequestration in modulating AKI.
1Section of Nephrology, University of Manitoba, Winnipeg, Manitoba, Canada
2Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada
3Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg, Manitoba, Canada
4Section of Cardiac Surgery, University of Manitoba, Winnipeg, Manitoba, Canada
Address correspondence to Martina Reslerova, MD, PhD, Assistant Professor, Section of Nephrology, University of Manitoba, St Boniface Hospital, 409 Tache Ave, Winnipeg Manitoba R2H 2A6, Canada
ABSTRACT